ADC texture - An imaging biomarker for high-grade glioma?

Medical Physics

Volumn 41, Issue 10, 2014, Pages

  Brynolfsson, Patrik ^a   Nilsson, David ^a   Henriksson, Roger ^a,b   Hauksson, Jón ^a   Karlsson, Mikael ^a   Garpebring, Anders ^a   Birgander, Richard ^a   Trygg, Johan ^a   Nyholm, Tufve ^a   Asklund, Thomas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ADC; glioma; multivariate image analysis; texture analysis

Indexed keywords

BIOMARKERS; DIAGNOSIS; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE TEXTURE; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; APPARENT DIFFUSION COEFFICIENT MAPS; CONTRAST ENHANCEMENT; GLIOMA; HIGH-GRADE GLIOMAS; IMAGING BIOMARKERS; MULTIVARIATE IMAGE ANALYSIS; PRE-TREATMENTS; PRINCIPAL-COMPONENT ANALYSIS; TEXTURE ANALYSIS;

TUMORS;

CONTRAST MEDIUM; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE;

ADJUVANT THERAPY; AGE DISTRIBUTION; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GLIOMA; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRINCIPAL COMPONENT ANALYSIS; RADIOLOGICAL PARAMETERS; TUMOR GROWTH; TUMOR REGRESSION; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGE; AGED; ANALOGS AND DERIVATIVES; BRAIN; BRAIN NEOPLASMS; CANCER GRADING; COMPUTER ASSISTED DIAGNOSIS; DISEASE COURSE; DRUG EFFECTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIATION RESPONSE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN; BRAIN NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; DACARBAZINE; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84907153252     PISSN: 00942405     EISSN: 24734209     Source Type: Journal    
DOI: 10.1118/1.4894812     Document Type: Article

References (41)

1. A. Omuro and L. M. DeAngelis, " Glioblastoma and other malignant gliomas: A clinical review," Jama-J. Am. Med. Assoc. 310 (17), 1842-1850 (2013). 10.1001/jama.2013.280319
2. R. Stupp et al., " Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma," N. Engl. J. Med. 352 (10), 987-996 (2005). 10.1056/NEJMoa043330
3. J. R. Shapiro, W. K. Yung, and W. R. Shapiro, " Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas," Cancer Res. 41 (6), 2349-2359 (1981).
4. R. Bonavia, M.-M. Inda, W. K. Cavenee, and F. B. Furnari, " Heterogeneity maintenance in glioblastoma: A social network," Cancer Res. 71 (12), 4055-4060 (2011). 10.1158/0008-5472.CAN-11-0153
5. E. Binda, A. Visioli, B. Reynolds, and A.L. Vescovi, " Heterogeneity of cancer-initiating cells within glioblastoma," Front. Biosci., Scholar Ed. 4, 1235-1248 (2012). 10.2741/S328
6. A. Sottoriva et al., " Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics," Proc. Natl. Acad. Sci. U. S. A. 110 (10), 4009-4014 (2013). 10.1073/pnas.1219747110
7. B. Lemasson et al., " Diffusion-weighted MRI as a biomarker of tumor radiation treatment response heterogeneity: A comparative study of whole-volume histogram analysis versus voxel-based functional diffusion map analysis," Transl. Oncol. 6 (5), 554-561 (2013). 10.1593/tlo.13532
8. M. Weller et al., " Personalized care in neuro-oncology coming of age: Why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice," Neuro. Oncol. 14 (Suppl. 4), iv100-iv108 (2012). 10.1093/neuonc/nos206
9. T. Hirai et al., " Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study," Am. J. Neuroradiol. 29 (8), 1505-1510 (2008). 10.3174/ajnr.A1121
10. R. Mangla et al., " Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma," Radiology 256 (2), 575-584 (2010). 10.1148/radiol.10091440
11. M. Law et al., " Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging," Radiology 247 (2), 490-498 (2008). 10.1148/radiol.2472070898
12. C. J. Galbán et al., " The parametric response map is an imaging biomarker for early cancer treatment outcome," Nat. Med. 15 (5), 572-576 (2009). 10.1038/nm.1919
13. S. Chawla et al., " Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck," Am. J. Roentgenol. 200 (1), 35-43 (2013). 10.2214/AJR.12.9432
14. M. A. Zahra, K. G. Hollingsworth, E. Sala, D. J. Lomas, and L. T. Tan, " Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy," Lancet Oncol. 8 (1), 63-74 (2007). 10.1016/S1470-2045(06)71012-9
15. T. L. Chenevert et al., " Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors," J. Natl. Cancer Inst. 92 (24), 2029-2036 (2000). 10.1093/jnci/92.24.2029
16. B. M. Ellingson et al., " Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.," Neuro. Oncol. 14 (3), 333-343 (2012). 10.1093/neuonc/nor220
17. B. M. Ellingson, T. F. Cloughesy, A. Lai, P. L. Nghiemphu, L. M. Liau, and W. B. Pope, " Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy," Neuro. Oncol. 15 (3), 382-390 (2013). 10.1093/neuonc/nos314
18. H. A. Rowley, P. E. Grant, and T. P. Roberts, " Diffusion MR imaging. Theory and applications," Neuroimaging Clin. N. Am. 9 (2), 343-361 (1999).
19. T. Sugahara et al., " Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas," J. Magn. Reson. Imaging 9 (1), 53-60 (1999). 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2
20. B. M. Ellingson et al., " Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity," J. Magn. Reson. Imaging 31 (3), 538-548 (2010). 10.1002/jmri.22068
21. K. Nie, J.-H. Chen, H. J. Yu, Y. Chu, O. Nalcioglu, and M.-Y. Su, " Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI," Acad. Radiol. 15 (12), 1513-1525 (2008). 10.1016/j.acra.2008.06.005
22. P. Georgiadis et al., " Enhancing the discrimination accuracy between metastases, gliomas and meningiomas on brain MRI by volumetric textural features and ensemble pattern recognition methods," Magn. Reson. Imaging 27 (1), 120-130 (2009). 10.1016/j.mri.2008.05.017
23. S. Chicklore, V. Goh, M. Siddique, A. Roy, P. K. Marsden, and G. J. R. Cook, " Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis," Eur. J. Nucl. Med. Mol. Imaging 40 (1), 133-140 (2013). 10.1007/s00259-012-2247-0
24. D. Assefa, H. Keller, C. Menard, N. Laperriere, R. J. Ferrari, and I. Yeung, " Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: A preliminary investigation in terms of identification and segmentation," Med. Phys. 37 (4), 1722-1736 (2010). 10.1118/1.3357289
25. S. Herlidou-Même et al., " MRI texture analysis on texture test objects, normal brain and intracranial tumors," Magn. Reson. Imaging 21 (9), 989-993 (2003). 10.1016/S0730-725X(03)00212-1
26. E. I. Zacharaki et al., " Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme," Magn. Reson. Med. 62 (6), 1609-1618 (2009). 10.1002/mrm.22147
27. H. Li et al., " Computerized analysis of mammographic parenchymal patterns on a large clinical dataset of full-field digital mammograms: Robustness study with two high-risk datasets," J. Digit. Imaging 25 (5), 591-598 (2012). 10.1007/s10278-012-9452-z
28. R. Brown et al., " The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma," Clin. Cancer Res. 14 (8), 2357-2362 (2008). 10.1158/1078-0432.CCR-07-1964
29. F. Tixier et al., " Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer," J. Nucl. Med. 52 (3), 369-378 (2011). 10.2967/jnumed.110.082404
30. H. Kang, H. Y. Lee, K. S. Lee, and J.-H. Kim, " Imaging-based tumor treatment response evaluation: Review of conventional, new, and emerging concepts.," Korean J. Radiol. 13 (4), 371-390 (2012). 10.3348/kjr.2012.13.4.371
31. P. Geladi, H. Isaksson, L. Lindqvist, S. Wold, and K. Esbensen, " Principal component analysis of multivariate images," Chemom. Intell. Lab. Syst. 5 (3), 209-220 (1989). 10.1016/0169-7439(89)80049-8
32. S. Wold, K. Esbensen, and P. Geladi, " Principal component analysis," Chemom. Intell. Lab. Syst. 2 (1-3), 37-52 (1987). 10.1016/0169-7439(87)80084-9
33. T. G. Reese, O. Heid, R. M. Weisskoff, and V. J. Wedeen, " Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo," Magn. Reson. Med. 49 (1), 177-182 (2003). 10.1002/mrm.10308
34. S. Klein, M. Staring, K. Murphy, M. A. Viergever, and J. P. W. Pluim, " elastix: A toolbox for intensity-based medical image registration," IEEE Trans. Med. Imaging 29 (1), 196-205 (2010). 10.1109/TMI.2009.2035616
35. Z. P. Liang, P. C. Lauterbur, and IEEE Engineering in Medicine and Biology Society, Principles of Magnetic Resonance Imaging: A Signal Processing Perspective (SPIE Optical Engineering, Bellingham, WA, 2000).
36. R. M. Haralick, K. Shanmugam, and I. Dinstein, " Textural features for image classification," IEEE Trans. Syst. Man. Cybern. 3 (6), 610-621 (1973). 10.1109/TSMC.1973.4309314
37. L. Soh, C. Tsatsoulis, and S. Member, " Texture analysis of SAR sea ice imagery using gray level co-occurence matrices," IEEE Trans. Geosci. Remote Sens. 37 (2), 780-795 (1999). 10.1109/36.752194
38. D. A. Clausi, " An analysis of co-occurrence texture statistics as a function of grey level quantization," Can. J. Remote Sens. 28 (1), 45-62 (2002). 10.5589/m02-004
39. P. C. Mahalanobis, " On the generalised distance in statistics," Proc. Natl. Inst. Sci. India 2 (1), 49-55 (1936). 10.3348/kjr.2012.13.4.371
40. M. Bylesjö, M. Rantalainen, O. Cloarec, J. K. Nicholson, E. Holmes, and J. Trygg, " OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classification," J. Chemom. 20 (8-10), 341-351 (2006). 10.1002/cem.1006
41. J. Juntu, J. Sijbers, S. De Backer, J. Rajan, and D. Van Dyck, " Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft-tissue tumors in T1-MRI images," J. Magn. Reson. Imaging 31 (3), 680-689 (2010). 10.1002/jmri.22095